|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Total revenues | |||||
| Operating expenses: | |||||
| Cost of revenues | |||||
| Total cost of revenues | |||||
| Selling and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Acquired in-process research and development | |||||
| Divestiture losses | |||||
| Loss on disposal of property and equipment | |||||
| Loss on disposal of assets, net | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other income (expenses): | |||||
| Interest income, net | |||||
| Other expense, net | |||||
| Other Income | |||||
| Change in fair value of warrant liability | |||||
| Other expenses | |||||
| Total income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Foreign currency translation adjustments | |||||
| Comprehensive income from operations | |||||
| Net income attributable to noncontrolling interest | |||||
| Foreign currency translation adjustments attributable to noncontrolling interest | |||||
| Comprehensive income attributable to noncontrolling interest | |||||
| Comprehensive income attributable to common stockholders | |||||
| Net income attributable to common stockholders | |||||
| Net income per share attributable to common stockholders, basic | |||||
| Net income per share attributable to common stockholders, diluted | |||||
| Weighted average shares used in calculating net income per share attributable to common stockholders, basic | |||||
| Weighted average shares used in calculating net income per share attributable to common stockholders, diluted | |||||
Loading...